<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression - Peng, L - 2014 | Cochrane Library</title> <meta content="Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression - Peng, L - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009763.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression - Peng, L - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009763.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009763.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression" name="citation_title"/> <meta content="Lihua Peng" name="citation_author"/> <meta content="The First Affiliated Hospital, Chongqing Medical University" name="citation_author_institution"/> <meta content="Su Min" name="citation_author"/> <meta content="The First Affiliated Hospital, Chongqing Medical University" name="citation_author_institution"/> <meta content="ms89011068@163.com" name="citation_author_email"/> <meta content="Ke Wei" name="citation_author"/> <meta content="The First Affiliated Hospital, Chongqing Medical University" name="citation_author_institution"/> <meta content="Patrick Ziemann‐Gimmel" name="citation_author"/> <meta content="Sheridan Healthcare" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD009763.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/04/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009763.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009763.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009763.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anesthetics, Intravenous [*administration &amp; dosage]; Depression [*therapy]; Electroconvulsive Therapy [*adverse effects]; Epilepsy, Tonic‐Clonic [*complications]; Etomidate [administration &amp; dosage]; Hypnotics and Sedatives [*administration &amp; dosage]; Methohexital [administration &amp; dosage]; Midazolam [administration &amp; dosage]; Propofol [administration &amp; dosage]; Randomized Controlled Trials as Topic; Thiamylal [administration &amp; dosage]; Thiopental [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009763.pub2&amp;doi=10.1002/14651858.CD009763.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="6nHUP32m";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009763\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009763\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fr","zh_HANS","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009763.pub2",title:"Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression",firstPublishedDate:"Apr 11, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009763.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009763.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009763.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009763.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009763.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009763.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009763.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009763.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009763.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009763.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3023 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009763.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-sec-0095"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-sec-0089"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/appendices#CD009763-sec-0100"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/table_n/CD009763StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/table_n/CD009763StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information#CD009763-cr-0002">Lihua Peng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information#CD009763-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Su Min</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information#CD009763-cr-0004">Ke Wei</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information#CD009763-cr-0005">Patrick Ziemann‐Gimmel</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information/en#CD009763-sec-0124">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 April 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009763.pub2">https://doi.org/10.1002/14651858.CD009763.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009763-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009763-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009763-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009763-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009763-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009763-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009763-abs-0001" lang="en"> <section id="CD009763-sec-0001"> <h3 class="title" id="CD009763-sec-0001">Background</h3> <p>Depression is a common mental disorder. It affects millions of people worldwide and is considered by the World Health Organization (WHO) to be one of the leading causes of disability. Electroconvulsive therapy (ECT) is a well‐established treatment for severe depression. Intravenous anaesthetic medication is used to minimize subjective unpleasantness and adverse side effects of the induced tonic‐clonic seizure. The influence of different anaesthetic medications on the successful reduction of depressive symptoms and adverse effects is unclear. </p> </section> <section id="CD009763-sec-0002"> <h3 class="title" id="CD009763-sec-0002">Objectives</h3> <p>This review evaluated the effects of different regimens of intravenous sedatives and hypnotics on anti‐depression efficacy, recovery and seizure duration in depressed adults undergoing ECT. </p> </section> <section id="CD009763-sec-0003"> <h3 class="title" id="CD009763-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2012, Issue 12); MEDLINE via Ovid SP (from 1966 to 31 December 2012); and EMBASE via Ovid SP (from 1966 to 31 December 2012). We handsearched related journals and applied no language restrictions. We reran the search in Feburary 2017. Four potential new studies of interest were added to a list of ‘Studies awaiting Classification' and will be incorporated into the formal review findings during the review update. </p> </section> <section id="CD009763-sec-0004"> <h3 class="title" id="CD009763-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) and cross‐over trials evaluating the effects of different intravenous sedatives and hypnotics for ECT. We excluded studies and trials using placebo or inhalational anaesthetics and studies that used no anaesthetic. </p> </section> <section id="CD009763-sec-0005"> <h3 class="title" id="CD009763-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trial quality and extracted data. When possible, data were pooled and risk ratios (RRs) and mean differences (MDs), each with 95% confidence intervals (CIs), were computed using the Cochrane Review Manager statistical package (RevMan). </p> </section> <section id="CD009763-sec-0006"> <h3 class="title" id="CD009763-sec-0006">Main results</h3> <p>We included in the review 18 RCTs (599 participants; published between 1994 and 2012). Most of the included trials were at high risk of bias. </p> <p>We analysed the results of studies comparing six different intravenous anaesthetics.</p> <p>Only a few studies comparing propofol with methohexital (four studies) and with thiopental (three studies) could be pooled. </p> <p>No difference was noted in the reduction of depression scores observed in participants treated with propofol compared with methohexital (low‐quality evidence). These four studies were not designed to detect differences in depression scores. </p> <p>The duration of electroencephalograph (EEG) and of motor seizures was shorter in the propofol group compared with the methohexital group (low‐quality evidence). No difference was seen in EEG seizure duration when propofol was compared with thiopental (low‐quality evidence). </p> <p>Time to recovery (following commands) was longer among participants after anaesthesia with thiopental compared with propofol (low‐quality evidence). </p> <p>For the remaining comparisons of anaesthetics, only single studies or insufficient data were available. Adverse events were inadequately reported in eligible trials, and none of the included trials reported anaesthesia‐related mortality. </p> </section> <section id="CD009763-sec-0007"> <h3 class="title" id="CD009763-sec-0007">Authors' conclusions</h3> <p>Most of the included studies were at high risk of bias, and the quality of evidence was generally low. The studies were not designed to detect clinically relevant differences in depression scores. Anaesthetic agents should be chosen on the basis of adverse effect profile, emergence and how these medications affect seizure duration. If it is difficult to elicit an adequately long seizure, methohexital may be superior to propofol (low‐quality evidence). If a patient is slow to recover from anaesthesia, propofol may allow a faster time to follow commands than thiopental (low‐quality evidence). A factor of clinical concern that was not addressed by any study was adrenal suppression from etomidate. Optimal dosages of intravenous sedatives or hypnotics have not yet been determined. </p> <p>Larger well‐designed randomized studies are needed to determine which intravenous anaesthetic medication leads to the greatest improvement in depression scores with minimal adverse effects. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009763-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009763-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009763-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009763-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009763-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ru#CD009763-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009763-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009763-abs-0004" lang="en"> <h3>Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression </h3> <p>Depression is a common mental disorder. It can present as loss of interest or pleasure, sadness, disturbed sleep or appetite, feelings of guilt or low self worth. In 2008, the World Health Organization (WHO) estimated that depression was the second leading cause of disability‐adjusted life‐years among all men and women between 15 and 44 years of age. The treatment of choice for severe and recurrent depression is electroconvulsive therapy (ECT). ECT involves the application of an electrical current to the patient's head. The aim is to induce a controlled convulsion. Patients usually undergo several sessions of ECT. </p> <p>To minimize adverse events and improve the quality of ECT, patients receive anaesthetic agents such as intravenous sedatives or hypnotics. These agents can influence the effectiveness of ECT but can cause potential adverse effects. It would be helpful to identify which is the best anaesthetic agent for ECT in this group of patients. </p> <p>This Cochrane review examined whether different types of anaesthetic agents could have an effect on anti‐depression therapy and reported on the safety of those agents. The evidence is current to December 2012. We included in this review 18 randomized controlled trials (599 participants). We analysed nine pairs of comparisons: methohexital versus propofol; thiopental versus propofol; etomidate versus propofol; thiopental versus etomidate; etomidate versus methohexital; methohexital versus midazolam; thiopental versus midazolam; midazolam versus propofol; and thiamylal versus propofol. </p> <p>Our analysis revealed no difference in the reduction of depression scores when methohexital was compared with propofol. Propofol reduced seizure duration to a greater extent than methohexital. No difference in seizure duration was noted when thiopental was compared with propofol. Patients recovered faster from anaesthesia when propofol rather than thiopental was used. Adverse events related to anaesthesia induction agents and to the treatment for depression were not well reported in most trials. We found the quality of the evidence to be low. Larger well‐designed randomized controlled trials are needed. More clinically relevant outcomes (such as remission of depressive symptoms and postanaesthetic adverse events) during a longer follow‐up period should be reported in future studies. </p> <p>We reran the search in Feburary 2017. Four potential new studies of interest were added to a list of ‘Studies awaiting Classification' and will be incorporated into the formal review findings during the review update. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009763-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009763-sec-0095"></div> <h3 class="title" id="CD009763-sec-0096">Implications for practice</h3> <section id="CD009763-sec-0096"> <p>The included studies were of low quality and were liable to bias. The studies were not designed to detect differences in depression scores. Anaesthetic agents should be chosen on the basis of adverse effect profile, emergence and how these medications affect seizure duration. If it is difficult to elicit an adequate seizure, methohexital or etomidate may be superior to propofol or thiopental. If emergence from anaesthesia is slow, propofol may be preferable to thiopental. A factor of clinical concern that was not addressed by any study was adrenal suppression from etomidate. Another concern was that different doses of anaesthetic medications were used in included studies (see <a href="#CD009763-tbl-0004">Table 2</a>). This could have affected seizure duration, time to emergence and incidence of adverse effects. </p> </section> <h3 class="title" id="CD009763-sec-0097">Implications for research</h3> <section id="CD009763-sec-0097"> <p>Larger well‐designed randomized controlled trials are needed to clarify the optimal intravenous sedatives or hypnotics for ECT. More clinically relevant outcomes (e.g. remission of depressive symptoms, postanaesthetic adverse events, cognitive adverse events after ECT) during a longer follow‐up period (longer than the immediate period after ECT) should be reported in future studies. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009763-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009763-sec-0029"></div> <div class="table" id="CD009763-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Methohexital compared with propofol for depressive patients receiving MECT</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Methohexital compared to propofol for depressive patients receiving MECT</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with depressive patients receiving MECT<br/> <b>Settings:</b> in‐patients and outpatients<br/> <b>Intervention:</b> methohexital<br/> <b>Comparison:</b> propofol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Propofol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Methohexital </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in Hamilton Depression Scale scores</b> <br/> Scale of Hamilton Depression scores<br/> Follow‐up: from start of ECT to 8 weeks after last session of ECT </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in Hamilton depression scores in the control groups was<br/> <b>the mean change in HDS before and after MECT treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in Hamilton Depression Scale scores in the intervention groups was<br/> <b>1.10 higher</b> <br/> (0.56 lower to 2.77 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>;<a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>;<a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>;<a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EEG seizure duration</b> <br/> EEG detection and measurement<br/> Follow‐up: from start of RCT (mean number as 2.5) to 2 months after ECT months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean EEG seizure duration in the control groups was<br/> <b>0 average participants (second)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean EEG seizure duration in the intervention groups was<br/> <b>7.42 higher</b> <br/> (0.39 to 14.4 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>;<a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Motor seizure duration</b> <br/> Direct observation of motor seizure<br/> Follow‐up: number of ECT sessions (6.6 to 7.8) per participant </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean motor seizure duration in the control groups was<br/> <b>0 seconds</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean motor seizure duration in the intervention groups was<br/> <b>5.87 higher</b> <br/> (1.97 to 9.77 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>;<a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Length of follow‐up period was different among included studies.<br/> <sup>2</sup>Small samples might render the pooled results imprecise.<br/> <sup>3</sup>All data were retrieved from published trials and no unpublished data were identified.<br/> <sup>4</sup>The report of all trials was published and no unpublished data were detected. </p> <p>5Heterogeneity might exist in baseline features of included participants.</p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009763-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Thiopental compared with propofol for patients receiving ECT</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Propofol versus thiopental</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with major depression treated with ECT<br/> <b>Settings:</b> in‐patients<br/> <b>Intervention:</b> thiopental<br/> <b>Comparison:</b> propofol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Propofol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Thiopental </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean EEG seizure duration</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 second</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2.26 seconds</b> <br/> (‐18.35 to 22.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; </p> <p><a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean time to recovery</b> <br/> Time to follow commands </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 minutes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1.72 minutes</b> <br/> (0.49 to 2.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>; </p> <p><a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Follow‐up durations were different among included studies.<br/> <sup>2</sup>Performance and detection bias were likely to happen in the trials.<br/> <sup>3</sup>Samples were small, which carries risk of inaccuracy.<br/> <sup>4</sup>Heterogeneity in baseline characteristics existed. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009763-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009763-sec-0030"></div> <section id="CD009763-sec-0031"> <h3 class="title" id="CD009763-sec-0031">Description of the condition</h3> <p>Depression is a common mental disorder that affects approximately 121 million people worldwide. Depression is considered one of the leading causes of disability (<a href="./references#CD009763-bbs2-0074" title="World Health Organization. WHO initiative on Depression in Public Health, 2008. http://www.who.int/mental_health/management/depression/definition/en/. ">WHO 2008</a>). Treatments for depression are diverse and include pharmacotherapy, cognitive‐behavioural therapy and psychotherapy. Electroconvulsive therapy (ECT) is considered for use in patients who are unresponsive to these interventions (refractory depression) (<a href="./references#CD009763-bbs2-0045" title="BarbuiC , CiprianiA , GeddesJR . Antidepressants and suicide symptoms: compelling new insights from the FDA’s analysis of individual patient level data. Evidence‐Based Mental Health2008;11(2):34‐5. [PUBMED: 18441126] ">Barbui 2008</a>; <a href="./references#CD009763-bbs2-0057" title="LeiknesKA , SchwederLJ , HøieB . Contemporary use and practice of electroconvulsive therapy worldwide. Brain and Behavior2012;2(3):283‐344. [PUBMED: 3381633] ">Leiknes 2012</a>). </p> </section> <section id="CD009763-sec-0032"> <h3 class="title" id="CD009763-sec-0032">Description of the intervention</h3> <p>ECT was first used to treat schizophrenia and was later found to be clinically effective in the treatment of depression (<a href="./references#CD009763-bbs2-0047" title="BernerP , Kryspin‐ExnerK , PoeldingerW . Therapy possibilities for therapy‐resistant depressions. Pharmakopsychiatrie, Neuro‐Psychopharmakologie1974;7(4):189‐93. [PUBMED: 4614274] ">Berner 1974</a>). Over subsequent decades, ECT was used to treat patients with various mental disorders, including affective disorders, delusion, suicidal intention, dysfunction of the vegetative nervous system, inanition and catatonia (<a href="./references#CD009763-bbs2-0061" title="RasmussenK . The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging. Journal of Electric Convulsive Therapy2001;18(1):58‐9. [PUBMED: 11925524] ">Rasmussen 2001</a>; <a href="./references#CD009763-bbs2-0070" title="ThompsonJW , WeinerRD , MyersCP . Use of ECT in the United States in 1975, 1980 and 1986. The American Journal of Psychiatry1994;151:1657‐61. [PUBMED: 7943457] ">Thompson 1994</a>). Technical variations of ECT involve the number and placement of electrodes or the energy dose and the electrical waveform of the stimulus. These factors may impact therapeutic outcomes. Current practice delivers a brief‐pulse current to induce a seizure (<a href="./references#CD009763-bbs2-0063" title="RudorferMV , HenryME , SackeimHA . Electroconvulsive therapy. Tasman A, Kay J, Lieberman JA. Psychiatry. Chichester: John Wiley &amp; Sons Ltd, 2003:1865–901. ">Rudorfer 2003</a>). </p> <p>ECT was originally performed without anaesthesia or sedation. Patients received an electrically induced convulsion or tonic‐clonic seizure to bring on remission or palliation of their depressive symptoms. This practice was reported to be associated with risk of cardiovascular events, post‐treatment muscle pains, joint injury, electrolyte imbalance and postictal cognitive impairment (<a href="./references#CD009763-bbs2-0042" title="AndradeC . Unmodified ECT: ethical issues. Issues in Medical Ethics2003;11(1):9‐10. [PUBMED: 16335495] ">Andrade 2003</a>; <a href="./references#CD009763-bbs2-0043" title="AndradeC , ShahN , TharyanP , ReddyMS , ThirunavukarasuM , KallivayalilRA , et al. Position statement and guidelines on unmodified electroconvulsive therapy. Indian Journal of  Psychiatry2012;52(4):119‐33. [PUBMED: 3440905] ">Andrade 2012</a>). With the introduction of intravenous anaesthetic drugs and muscle relaxants, ECT was performed increasingly with anaesthesia. This approach is termed modified ECT. Modified ECT (mECT) provides the merits of increased safety and patient comfort along with fewer procedure‐associated adverse events (<a href="./references#CD009763-bbs2-0064" title="SackeimHA , RossFR , HopkinsN , CalevL , DevanandDP . Subjective side effects acutely following ECT: associations with treatment modality and clinical response. Convulsion Therapy1987;3(2):100‐10. [PUBMED: 0749‐8055] ">Sackeim 1987</a>). Today almost all clinicians regard mECT as the standard practice (<a href="./references#CD009763-bbs2-0046" title="BergJE . Electroconvulsive treatment—more than electricity? An Odyssey of facilities. The Journal of ECT2009;25(4):250‐5. [PUBMED: 19458536] ">Berg 2003</a>; <a href="./references#CD009763-bbs2-0069" title="SwartzCM . Electroconvulsive and Neuro‐modulation Therapies. Cambridge: Cambridge University Press, 2009. ">Swartz 2009</a>), and in this review, mECT is referred to as ECT. </p> </section> <section id="CD009763-sec-0033"> <h3 class="title" id="CD009763-sec-0033">How the intervention might work</h3> <p>The exact mechanism of how ECT helps to reduce depressive symptoms is unclear (<a href="./references#CD009763-bbs2-0060" title="MerklA , HeuserI , BajboujM . Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations. Experimental Neurology2009;219(1):20‐6. [PUBMED: 19426729] ">Merkl 2009</a>). Previous studies have shown that longer seizure duration may be associated with improved anti‐depressive efficacy (<a href="./references#CD009763-bbs2-0065" title="SackeimHA , PrudicJ , DevanandDP , KierskyJE , FitzsimonsL , MoodyBJ , et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New England Journal of Medicine1993;328:839–46. [PUBMED: 8441428] ">Sackeim 1993</a>; <a href="./references#CD009763-bbs2-0073" title="WeinerRD . The psychiatric use of electrically induced seizures. Psychiatry1979;136:1507‐17. [PUBMED: 389068 ] ">Weiner 1979</a>), but considerable debate and controversy are ongoing. No consensus has been reached regarding the established association between anti‐depression efficacy and seizure duration. Most trials have reported this outcome as the main index of seizure quality and as a possible surrogate of anti‐depression efficacy. This review sought to evaluate both anti‐depression scores and seizure duration. </p> </section> <section id="CD009763-sec-0034"> <h3 class="title" id="CD009763-sec-0034">Why it is important to do this review</h3> <p>Anaesthetics and hypnotics possess anticonvulsant properties that could modify seizure activity and duration (<a href="./references#CD009763-bbs2-0066" title="SackheimHA , DevanadDP , PrudicJ . Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. The Psychiatric Clinics of North America1991;14:803‐43. [PUBMED: 1771150] ">Sackheim 1991</a>). The range of intravenous sedatives and hypnotics is large, but the most commonly used and widely studied anaesthetic agents are methohexital, propofol and etomidate (<a href="./references#CD009763-bbs2-0056" title="HootenWM , RasmussenKG . Effects of general anaesthetic agents in adults receiving electroconvulsive therapy: a systematic review. The Journal of ECT2008;24:208‐23. [PUBMED: 18628717] ">Hooten 2008</a>). The influence of different types of anaesthetic medications on the successful reduction of depressive symptoms, on adverse effects or on seizure duration of ECT is unclear. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009763-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009763-sec-0035"></div> <p>This review evaluated the effects of different regimens of intravenous sedatives and hypnotics on anti‐depression efficacy, recovery and seizure duration in depressed adults undergoing ECT. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009763-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009763-sec-0036"></div> <section id="CD009763-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009763-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included all randomized controlled trials (RCTs) that met the following inclusion criteria: trials that evaluated different regimens of intravenous sedatives and hypnotics during general anaesthesia for ECT and their effects on remission of depression, cognitive recovery and safety of the anaesthesia. We included cross‐over trials. We included studies irrespective of language and publication status. </p> <p>We excluded:</p> <p> <ol id="CD009763-list-0001"> <li> <p>prospective cohort studies and quasi‐randomized studies;</p> </li> <li> <p>trials reported as ECT without the use of any anaesthetic; and</p> </li> <li> <p>RCTs that compared placebo or inhalation anaesthetic agents with intravenous sedatives and hypnotics. </p> </li> </ol> </p> </section> <section id="CD009763-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included adult participants (16 years of age or older) with major depressive disorder and depressive episodes of bipolar disorder according to the <i>Diagnostic and Statistical Manual of Mental Disorders</i> (<i>DSM)‐IV/ DSM‐III</i> and equivalent diagnoses of the <i>International Classification of Diseases (ICD)‐10</i> /<i>ICD‐9</i> (<a href="./references#CD009763-bbs2-0041" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000. ">American Psychiatric Association 2000</a>) who were eligible for ECT under general anaesthetic management. </p> <p>Participants received intravenous sedatives or hypnotics with or without other types of anaesthetic medications (except for inhalational agents) during the induction phase. </p> </section> <section id="CD009763-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included all RCTs that compared different types of intravenous sedatives or hypnotics used as induction agents for ECT, including: </p> <p> <ol id="CD009763-list-0002"> <li> <p>intravenous sedative or hypnotic (treatment group) versus another intravenous sedative or hypnotic; </p> </li> <li> <p>intravenous sedative or hypnotic combined with a muscle relaxant versus another intravenous sedative or hypnotic combined with the same muscle relaxant; </p> </li> <li> <p>intravenous sedative or hypnotic combined with an analgesic versus another intravenous sedative or hypnotic combined with the same analgesic; or </p> </li> <li> <p>intravenous sedative or hypnotic combined with an analgesic and a muscle relaxant versus another intravenous sedative or hypnotic combined with the same analgesic and muscle relaxant. </p> </li> </ol> </p> <p>Because ketamine was not an established intravenous sedative or hypnotic for both its excitatory and inhibitory effects on the central nervous system (CNS) (<a href="./references#CD009763-bbs2-0049" title="DuncanWCJr , ZarateCAJr . Ketamine, sleep, and depression: current status and new questions. Current Psychiatry Reports2013;15(9):394. [PUBMED: 23949569] ">Duncan 2013</a>), it was excluded from the scope of this review. </p> </section> <section id="CD009763-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD009763-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009763-list-0003"> <li> <p>Remission of depressive symptoms (risk and score reduction) (using validated international scales for measures of depressive symptoms) (see <a href="#CD009763-tbl-0003">Table 1</a>). </p> </li> <li> <p>ECT‐induced seizure electroencephalogram (EEG) duration (time in seconds).</p> </li> <li> <p>ECT‐induced seizure motor duration (time in seconds) (muscular contractions observed and measured by stopwatch–hand/limb‐cuff method). </p> </li> <li> <p>Anaesthesia‐related mortality and morbidity (lung aspiration, cardiac arrest, severe allergy). </p> </li> </ol> </p> <div class="table" id="CD009763-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">List of abbreviations used in this review</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abbreviation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Full name</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ECT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electroconvulsive therapy (synonym for modified electrioconvulsive therapy in this review) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MADRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Montgomery‐Asberg Depression Scale</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HDRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hamilton Depression Rating Scale</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>WHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World Health Orgnization</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DALY</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disability‐adjusted life‐year</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>*</p> </div> </div> </section> <section id="CD009763-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD009763-list-0004"> <li> <p>Recovery time (time to emergence and time to recovery).</p> </li> <li> <p>Rate of postanaesthetic cognitive adverse events (confusion/delirium/agitation).</p> </li> <li> <p>Postanaesthetic nausea and vomiting.</p> </li> <li> <p>Injury to and adverse events of systems other than those mentioned above.</p> </li> </ol> </p> </section> </section> </section> <section id="CD009763-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009763-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2012, issue 12); MEDLINE via Ovid SP (from 1966 to 31 December 2012); and EMBASE via Ovid SP (from 1966 to 31 December 2012). We searched as well the World Health Organization International Clinical Trials Registry Platform (ICTRP) (up to 31 December 2012) and clinicaltrials.gov (up to 31 December 2012). </p> <p>We combined the sensitive strategies described in Section 6.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009763-bbs2-0053" title="Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>) to search for RCTs in MEDLINE and EMBASE. We used the free text and associated exploded MeSH terms found in <a href="./appendices#CD009763-sec-0101">Appendix 1</a> in combination with the RCT sensitive search strategy. We incorporated into the search strategy any new terms that were identified. We adapted our MEDLINE search strategy for searching in CENTRAL (see <a href="./appendices#CD009763-sec-0102">Appendix 2</a>), and we searched EMBASE using the terms found in <a href="./appendices#CD009763-sec-0103">Appendix 3</a>. We reported the modified search strategy in full in this review. </p> <p>We applied no language restrictions.</p> <p>We reran the search in Feburary 2017. We will deal with the potential studies of interest when we update the review. </p> </section> <section id="CD009763-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We screened the reference lists of all eligible trials and reviews. We intended to contact experts to identify any unpublished research and trials still under way. However, all potentially eligible trials were already published. </p> <p>We searched the following databases for ongoing trials: MetaRegister of ControlledTrials and the National Research Register. Free text terms were used in all databases and in combination with subject headings when these were components of a database (see <a href="./appendices#CD009763-sec-0101">Appendix 1</a>, <a href="./appendices#CD009763-sec-0102">Appendix 2</a> and <a href="./appendices#CD009763-sec-0103">Appendix 3</a>). </p> <p>We searched international conference and consortium articles for finished or ongoing trials of potential value. </p> <p> <ol id="CD009763-list-0005"> <li> <p>Annual Conference of American Society of Anaesthesiologists (2000 to 2012).</p> </li> <li> <p>Annual Conference of American Psychiatric Association (2000 to 2012).</p> </li> <li> <p>Annual European Congress of Psychiatry (2000 to 2012).</p> </li> </ol> </p> <p>We also searched the following related journals.</p> <p> <ol id="CD009763-list-0006"> <li> <p><i>Journal of Electric Convulsive Therapy</i> (1990 to 2012). </p> </li> <li> <p><i>Amercian Journal of Psychiatry</i> (1990 to 2012). </p> </li> <li> <p><i>Anesthesia and Analgesia</i> (1990 to 2012). </p> </li> <li> <p><i>Anesthesiology</i> (1990 to 2012). </p> </li> </ol> </p> </section> </section> <section id="CD009763-sec-0047"> <h3 class="title" id="CD009763-sec-0047">Data collection and analysis</h3> <section id="CD009763-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors (Peng Lihua and Wei Ke) independently screened all titles and abstracts for eligibility according to the study inclusion criteria (see <a href="#CD009763-sec-0037">Criteria for considering studies for this review</a>). We included eligible cross‐over trials. We contacted the first author of the relevant trial if further information was required to make a decision about including a trial. We resolved disagreements by discussion. If we were unable to reach a consensus, we consulted with a third review author (Min Su). We based our decision for including or excluding a study on the full text of the study, if available. We recorded data from included studies on a specially developed form (see <a href="./appendices#CD009763-sec-0104">Appendix 4</a>). </p> </section> <section id="CD009763-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (Min Su and Wei Ke) independently extracted and reported data on specially designed forms (see <a href="./appendices#CD009763-sec-0104">Appendix 4</a>). We assessed methodological quality using predefined criteria (see <a href="./appendices#CD009763-sec-0105">Appendix 5</a>). Data extraction was checked by a third review author (Peng Lihua). We resolved disagreements concerning data extraction by consensus with two review authors, based on the above predefined criteria. For detailed information on the included trials and their outcomes in uniform tables, see <a href="./appendices#CD009763-sec-0106">Appendix 6</a> and <a href="./appendices#CD009763-sec-0107">Appendix 7</a>. We double‐checked our data entry into <a href="./references#CD009763-bbs2-0062" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 5.1</a>. In the case of further disagreement, we consulted a third review author (Peng Lihua). </p> </section> <section id="CD009763-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (Wei Ke and Peng Lihua) independently assessed the risk of bias of all eligible trials. We resolved disagreements by discussion, and if we could not reach a consensus, a third review author (Min Su) arbitrated. </p> <p>We performed risk of bias assessment using the 'Risk of bias' tool described in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009763-bbs2-0053" title="Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). A copy of the form that we used will be found in <a href="./appendices#CD009763-sec-0105">Appendix 5</a>. </p> <p>We assessed each trial according to the quality domains of random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting and other biases. </p> <p> <ol id="CD009763-list-0007"> <li> <p>Random sequence generation: adequate (random numbers generated by a computer or similar) or inadequate (other methods or not described). </p> </li> <li> <p>Allocation concealment: adequate (sealed envelopes or similar) or inadequate (not described, open table of random numbers or similar). </p> </li> <li> <p>Blinding: indexed as adequate (investigator who assessed clinical outcomes did not know whether the participant undertook the intervention or similar) or inadequate (not performed or similar). </p> </li> <li> <p>Intention‐to treat (ITT): ITT considered adequate if all dropouts or withdrawals were accounted for; ITT considered inadequate if the number of dropouts or withdrawals was not stated, or if the reasons for any dropouts or withdrawals were not stated. </p> </li> </ol> </p> <p>We considered a trial as having a low risk of bias if all domains were assessed as adequate. We considered a trial as having a high risk of bias if one or more domains were assessed as inadequate or unclear. </p> <p>We reported the 'Risk of bias' table as part of the table <a href="./references#CD009763-sec-0130" title="">Characteristics of included studies</a> and presented a 'Risk of bias summary' figure, which detailed all of the judgements made for all included studies in the review. </p> </section> <section id="CD009763-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We performed all analyses according to the ITT principle, including all randomly assigned participants. We presented categorical and dichotomous outcomes as risk ratios (RRs) with 95% confidence intervals (CIs) when meta‐analysis was possible. The absolute harm or benefit was calculated in the summary of finding (SOF) tables using a standard calculation formula as absolute differences. For continuous outcomes such as seizure duration, we used means and standard deviations (SDs) to summarize and analyse the value in each group. </p> </section> <section id="CD009763-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>If continuous data were appropriately reported (mean with standard deviation or standard error, or mean difference), we combined cross‐over studies with RCTs in the meta‐analysis and performed a sensitivity analysis. If multiple treatment arms existed, we combined groups to create a single pair‐wise comparison. Outcomes assessed during and after the ECT procedure were analysed separately. If pair‐wise data for before and after are reported for each participant or for each arm, we reported change scores using recommendations from the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009763-bbs2-0053" title="Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>; 16.1.3.2). </p> </section> <section id="CD009763-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>We contacted the original investigators to obtain missing data when possible. If we were unable to contact the original investigators or to obtain missing data, we used mean values. We then performed sensitivity analyses to assess how sensitive the results were to reasonable changes in assumptions made. In the discussion section of the review, we addressed the potential impact of missing data on the findings of the review. </p> </section> <section id="CD009763-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the clinical heterogeneity of the included studies according to their clinical diversity (e.g. gender, position and number of stimulation electrodes, premedication or no premedication) and as methodological diversity (risk of bias assessment). We assessed statistical heterogeneity using the I<sup>2</sup> statistic, thereby estimating the percentage of total variance across studies that is due to heterogeneity rather than to chance (<a href="./references#CD009763-bbs2-0052" title="HigginsJ , ThomsonS . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21(11):1539–58. [DOI: 10.1002/sim.1186] ">Higgins 2002</a>). We considered an I<sup>2</sup> value greater than 50% as statistically significant. If significant heterogeneity was found, we again checked that data were correct and explored the reasons for the heterogeneity. When heterogeneity could not be explained readily, we conducted a meta‐analysis using the random‐effects model. </p> </section> <section id="CD009763-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We performed comprehensive searches for studies that met our eligibility criteria, including, when possible, unpublished studies and trial registries. We used funnel plots to assess reporting biases. We tested for funnel plot asymmetry if more than 10 studies were included in the meta‐analysis. </p> </section> <section id="CD009763-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We used the fixed‐effect model in the meta‐analyses if no obvious heterogeneity was found. However, when heterogeneity was detected that could not be explained readily, we conducted a meta‐analysis using the random‐effects model. We performed all analyses according to the ITT principle. For trials reported with multiple intervention groups, we combined groups to create a single pair‐wise comparison. This method is suitable for trials reporting several independent comparisons and making multiple pair‐wise comparisons. </p> <p>For dichotomous outcomes, both the sample size and the number of participants across groups were summed. For continuous outcomes, weighted mean differences were combined using the formula in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009763-bbs2-0053" title="Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>; see Table 7.7.a). We assessed heterogeneity using a random‐effects model. </p> </section> <section id="CD009763-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We analysed the association between different kinds and dosages of experimental interventions and intervention effects. </p> <p>We planned to perform subgroup analyses for subgroups of participants and for subgroups of interventions when data were available. </p> <section id="CD009763-sec-0058"> <h5 class="title">Subgroups of participants</h5> <p> <ol id="CD009763-list-0008"> <li> <p>Sex.</p> </li> <li> <p>Age over 60 years.</p> </li> <li> <p>Disease stage (newly diagnosed, disease relapsed).</p> </li> <li> <p>Major depression or bipolar disorder.</p> </li> <li> <p>Number and sites of electrode positioning.</p> </li> <li> <p>Energy of electric stimulus.</p> </li> </ol> </p> </section> </section> <section id="CD009763-sec-0059"> <h4 class="title">Sensitivity analysis</h4> <p>To test whether included trials with variations in methodological design or trials with only abstracts available could bias the results of the meta‐analysis, we performed sensitivity analyses of trials labelled as having low risk or high risk of bias. A random‐effects estimate was calculated when significant heterogeneity was found for each outcome variable. We initially included all studies and then eliminated studies of moderate or poor quality, as well as those published only as an abstract, one at a time to see if this approach altered the results. Finally, the analysis was performed with data from studies of good methodological quality; thus the sensitivity analyses were done in a multiple‐step way. In the case of missing data, we planned to use best case/worst case imputation of missing data. We excluded and re‐included any study that appeared to have a large effect size (often the largest or earliest study) to assess its impact on the meta‐analysis. If large variations in the control group event rate were noted, we also subjected these data to sensitivity analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009763-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009763-sec-0060"></div> <section id="CD009763-sec-0061"> <h3 class="title">Description of studies</h3> <p>See <a href="#CD009763-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009763-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009763-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>After screening 425 articles related to the topic, we included 18 trials in this review. One study (<a href="./references#CD009763-bbs2-0040" title="The relationship between anaesthetic induction agent type or dose and clinical outcome in patients with depression undergoing electroconvulsive therapy (ECT). Ongoing study 01/03/2003. ">Godfrey 2011</a>) is ongoing (see <a href="./references#CD009763-sec-0133" title="">Characteristics of ongoing studies</a>). </p> <p>All 18 trials were published between 1994 and 2012, and a total of 599 participants were included in the analysis. Two trials reported identical groups of participants with different endpoints (<a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a>). These participants were counted only once. The average number of ECT sessions varied from three to 11.3 for each participant. Two trials reported significantly unequal numbers of ECT sessions between two interventions. The remaining eligible trials reported equal or balanced numbers of ECT sessions. Follow‐up assessment ranged from after the first ETC session up to eight weeks after the last treatment. </p> <p>The number of enrolled participants in each study ranged from 10 to 90 (median 28). The age range was 18 to 81 years. </p> <p>We found nine pairs of comparisons for different sedatives or hypnotics in these trials</p> <p>We reran the literature research in Feburary 2017, 1076 articles were found and four studies were potential new studies of interest. These four studies were added to a list of ‘Studies awaiting Classification' and will be incorporated into the formal review findings during the review update.’ </p> <section id="CD009763-sec-0062"> <h4 class="title">Propofol versus</h4> <p>1. Methohexital (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>; <a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>; <a href="./references#CD009763-bbs2-0008" title="FredmanB , d'EtienneJ , SmithI , HusainMM , WhitePF . Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesthesia and Analgesia1994;79:75‐9. [MEDLINE: 8010457] ">Fredman 1994</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a>; <a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>; <a href="./references#CD009763-bbs2-0014" title="MattersRM , BeckettWG , KirkbyKC , KingTE . Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. British Journal of Anesthesia1995;75:297‐300. [MEDLINE: 7547047] ">Matters 1995</a>). </p> <p>2. Thiopental (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0005" title="ButterfieldNN , GrafP , MacleodBA , RiesCR , ZisAP . Propofol reduces cognitive impairment after electroconvulsive therapy. The Journal of ECT2004;20:3‐9. [MEDLINE: 5087989] ">Butterfield 2004</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a>; <a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a>). </p> <p>3. Etomidate (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>; <a href="./references#CD009763-bbs2-0006" title="ErdilF , DemirbilekS , BegecZ , OzturkE , ErsoyMO . Effects of propofol or etomidate on QT interval during electroconvulsive therapy. The Journal of ECT2009;25:174‐7. [MEDLINE: 19225403] ">Erdil 2009</a>; <a href="./references#CD009763-bbs2-0010" title="GratiL , LouziM , NasrK , ZiliN , MansalliL , MechriA , et al. [Compared effects of etomidate and propofol for anaesthesia during electroconvulsive therapy] (Article in French). La Presse Médicale2005;34:282‐4. [MEDLINE: 15798546] ">Grati 2005</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a>). </p> <p>4. Thiamylal (<a href="./references#CD009763-bbs2-0017" title="SakamotoA , HoshinoT , SuzukiN , SuzukiH , KimuraM , OgawaR . Effects of propofol anaesthesia on cognitive recovery of patients undergoing electroconvulsive therapy. Psychiatry and Clinical Neurosciences1999;53:655‐60. [MEDLINE: 10687746] ">Sakamoto 1999</a>). </p> <p>5. Midazolam (<a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a>). </p> </section> <section id="CD009763-sec-0063"> <h4 class="title">Methohexital versus</h4> <p>6. Etomidate (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>). </p> <p>7. Midazolam (<a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>). </p> </section> <section id="CD009763-sec-0064"> <h4 class="title">Thiopental versus</h4> <p>8. Etomidate (<a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a>). </p> <p>9. Midazolam (<a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a>). </p> <p>The different sedatives or hypnotics were used in combination with succinylcholine.</p> <p>The dose of propofol ranged from 0.75 to 2.5 mg/kg; methohexital 0.75 to 1.5 mg/kg; thiopental 2 to 5 mg/kg; etomidate 0.15 to 0.3 mg/kg; midazolam 0.1 to 0.2 mg/kg; thiamylal 1 mg/kg; and succinylcholine 0.4 to 1.5 mg/kg (see <a href="#CD009763-tbl-0004">Table 2</a>). </p> <div class="table" id="CD009763-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Doses of anaesthetics in mg/kg</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methohexital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thiopental</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Etomidate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Midazolam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thiamylal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75‐1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75‐1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15‐0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0008" title="FredmanB , d'EtienneJ , SmithI , HusainMM , WhitePF . Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesthesia and Analgesia1994;79:75‐9. [MEDLINE: 8010457] ">Fredman 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0014" title="MattersRM , BeckettWG , KirkbyKC , KingTE . Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. British Journal of Anesthesia1995;75:297‐300. [MEDLINE: 7547047] ">Matters 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0005" title="ButterfieldNN , GrafP , MacleodBA , RiesCR , ZisAP . Propofol reduces cognitive impairment after electroconvulsive therapy. The Journal of ECT2004;20:3‐9. [MEDLINE: 5087989] ">Butterfield 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0‐1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0‐3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0017" title="SakamotoA , HoshinoT , SuzukiN , SuzukiH , KimuraM , OgawaR . Effects of propofol anaesthesia on cognitive recovery of patients undergoing electroconvulsive therapy. Psychiatry and Clinical Neurosciences1999;53:655‐60. [MEDLINE: 10687746] ">Sakamoto 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0‐2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0010" title="GratiL , LouziM , NasrK , ZiliN , MansalliL , MechriA , et al. [Compared effects of etomidate and propofol for anaesthesia during electroconvulsive therapy] (Article in French). La Presse Médicale2005;34:282‐4. [MEDLINE: 15798546] ">Grati 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> <p>Ten trials reported the change in depression scores before and after ECT.</p> <p>Sixteen trials reported motor seizure duration. Twelve included trials reported time to recovery. </p> <p>None of the included trials reported anaesthesia‐related mortality. Only three trials reported postanaesthetic adverse events. </p> <p>The only studies that showed a low risk of bias were <a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>. and <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>. The remaining studies showed a high risk of bias. For detailed information on the risk of bias, see <a href="#CD009763-fig-0002">Figure 2</a> and <a href="#CD009763-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009763-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009763-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009763-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009763-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>For additional methodological details, please see <a href="./references#CD009763-sec-0130" title="">Characteristics of included studies</a>. </p> </section> <section id="CD009763-sec-0065"> <h4 class="title">Results of the search</h4> <p>See above section (description of study).</p> </section> <section id="CD009763-sec-0066"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD009763-sec-0130" title="">Characteristics of included studies</a>. </p> <p> <ol id="CD009763-list-0009"> <li> <p>Methohexital versus midazolam (<a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>). </p> </li> <li> <p>Methohexital versus propofol (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>; <a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>; <a href="./references#CD009763-bbs2-0008" title="FredmanB , d'EtienneJ , SmithI , HusainMM , WhitePF . Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesthesia and Analgesia1994;79:75‐9. [MEDLINE: 8010457] ">Fredman 1994</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a>; <a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>). </p> </li> <li> <p>Thiopental versus propofol (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0005" title="ButterfieldNN , GrafP , MacleodBA , RiesCR , ZisAP . Propofol reduces cognitive impairment after electroconvulsive therapy. The Journal of ECT2004;20:3‐9. [MEDLINE: 5087989] ">Butterfield 2004</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a>; <a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a>). </p> </li> <li> <p>Etomidate versus propofol (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>; <a href="./references#CD009763-bbs2-0006" title="ErdilF , DemirbilekS , BegecZ , OzturkE , ErsoyMO . Effects of propofol or etomidate on QT interval during electroconvulsive therapy. The Journal of ECT2009;25:174‐7. [MEDLINE: 19225403] ">Erdil 2009</a>; <a href="./references#CD009763-bbs2-0010" title="GratiL , LouziM , NasrK , ZiliN , MansalliL , MechriA , et al. [Compared effects of etomidate and propofol for anaesthesia during electroconvulsive therapy] (Article in French). La Presse Médicale2005;34:282‐4. [MEDLINE: 15798546] ">Grati 2005</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a>). </p> </li> <li> <p>Thiopental versus etomidate (<a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a>). </p> </li> <li> <p>Thiamylal versus propofol (<a href="./references#CD009763-bbs2-0017" title="SakamotoA , HoshinoT , SuzukiN , SuzukiH , KimuraM , OgawaR . Effects of propofol anaesthesia on cognitive recovery of patients undergoing electroconvulsive therapy. Psychiatry and Clinical Neurosciences1999;53:655‐60. [MEDLINE: 10687746] ">Sakamoto 1999</a>). </p> </li> <li> <p>Thiopental versus midazolam (<a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a>). </p> </li> <li> <p>Midazolam versus propofol (<a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a>). </p> </li> <li> <p>Methohexital versus midazolam (<a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>). </p> </li> </ol> </p> <p>The different sedatives or hypnotics were used in combination with muscle relaxants (succinylcholine). </p> <p>The dose of propofol ranged from 0.75 to 2.5 mg/kg; methohexital 0.75 to 1.5 mg/kg; thiopental 2 to 5 mg/kg; etomidate 0.15 to 0.3 mg/kg; midazolam 0.1 to 0.2 mg/kg; thiamylal 1 mg/kg; and succinylcholine 0.4 to 1.5 mg/kg (see <a href="#CD009763-tbl-0004">Table 2</a>). </p> <p>None of the eligible trials used analgesics.</p> <section id="CD009763-sec-0067"> <h5 class="title">Outcomes</h5> <section id="CD009763-sec-0068"> <h6 class="title">Primary outcomes</h6> <section id="CD009763-sec-0069"> <p><b>Efficacy of anti‐depression (change in depression score before and after ECT)</b></p> <p>Ten trials reported the change in depression score before and after ECT (<a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a>; <a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>; <a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>; <a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a>). </p> </section> <section id="CD009763-sec-0070"> <p><b>Seizure quality (EEG or motor seizure duration)</b></p> <p>All included trials reported motor seizure duration. EEG seizure duration was not reported in two trials (<a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a>; <a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>). </p> <p>Four trials reported use of the cuff method for assessing motor seizure duration (<a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>; <a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>; <a href="./references#CD009763-bbs2-0005" title="ButterfieldNN , GrafP , MacleodBA , RiesCR , ZisAP . Propofol reduces cognitive impairment after electroconvulsive therapy. The Journal of ECT2004;20:3‐9. [MEDLINE: 5087989] ">Butterfield 2004</a>; <a href="./references#CD009763-bbs2-0006" title="ErdilF , DemirbilekS , BegecZ , OzturkE , ErsoyMO . Effects of propofol or etomidate on QT interval during electroconvulsive therapy. The Journal of ECT2009;25:174‐7. [MEDLINE: 19225403] ">Erdil 2009</a>), Six trials reported visual observation of motor seizure duration (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>; <a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>; <a href="./references#CD009763-bbs2-0008" title="FredmanB , d'EtienneJ , SmithI , HusainMM , WhitePF . Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesthesia and Analgesia1994;79:75‐9. [MEDLINE: 8010457] ">Fredman 1994</a>; <a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a>; <a href="./references#CD009763-bbs2-0014" title="MattersRM , BeckettWG , KirkbyKC , KingTE . Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. British Journal of Anesthesia1995;75:297‐300. [MEDLINE: 7547047] ">Matters 1995</a>) and the rest of the eligible trials did not report methods of assessing motor seizure duration. </p> </section> <section id="CD009763-sec-0071"> <p><b>Anaesthesia‐related mortality</b></p> <p>No included trials reported anaesthesia‐related mortality.</p> </section> </section> <section id="CD009763-sec-0072"> <h6 class="title">Secondary outcomes</h6> <section id="CD009763-sec-0073"> <p><b>Recovery time</b></p> <p>Twelve included trials reported time to recovery (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>; <a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0005" title="ButterfieldNN , GrafP , MacleodBA , RiesCR , ZisAP . Propofol reduces cognitive impairment after electroconvulsive therapy. The Journal of ECT2004;20:3‐9. [MEDLINE: 5087989] ">Butterfield 2004</a>; <a href="./references#CD009763-bbs2-0006" title="ErdilF , DemirbilekS , BegecZ , OzturkE , ErsoyMO . Effects of propofol or etomidate on QT interval during electroconvulsive therapy. The Journal of ECT2009;25:174‐7. [MEDLINE: 19225403] ">Erdil 2009</a>; <a href="./references#CD009763-bbs2-0008" title="FredmanB , d'EtienneJ , SmithI , HusainMM , WhitePF . Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesthesia and Analgesia1994;79:75‐9. [MEDLINE: 8010457] ">Fredman 1994</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>; <a href="./references#CD009763-bbs2-0014" title="MattersRM , BeckettWG , KirkbyKC , KingTE . Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. British Journal of Anesthesia1995;75:297‐300. [MEDLINE: 7547047] ">Matters 1995</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a>; <a href="./references#CD009763-bbs2-0017" title="SakamotoA , HoshinoT , SuzukiN , SuzukiH , KimuraM , OgawaR . Effects of propofol anaesthesia on cognitive recovery of patients undergoing electroconvulsive therapy. Psychiatry and Clinical Neurosciences1999;53:655‐60. [MEDLINE: 10687746] ">Sakamoto 1999</a>; <a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a>). </p> </section> <section id="CD009763-sec-0074"> <p><b>Postanaesthetic adverse events</b></p> <p>Only three trials reported postanaesthetic adverse events (<a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a>; <a href="./references#CD009763-bbs2-0010" title="GratiL , LouziM , NasrK , ZiliN , MansalliL , MechriA , et al. [Compared effects of etomidate and propofol for anaesthesia during electroconvulsive therapy] (Article in French). La Presse Médicale2005;34:282‐4. [MEDLINE: 15798546] ">Grati 2005</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>). </p> </section> </section> </section> </section> <section id="CD009763-sec-0075"> <h4 class="title">Excluded studies</h4> <p>We excluded 17 articles for the reasons detailed in the <a href="./references#CD009763-sec-0131" title="">Characteristics of excluded studies</a> tables. These reasons included the following. </p> <p> <ol id="CD009763-list-0010"> <li> <p>Non‐eligible groups of patients.</p> </li> <li> <p>Non‐randomized controlled trials.</p> </li> <li> <p>Anaesthesia agents used as premedication, not as induction agents (<a href="./references#CD009763-bbs2-0028" title="MizrakA , KorukS , GanidagliS , BulutM , OnerU . Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy. Journal of Anesthesia2009;23(1):6‐10. [MEDLINE: 19234815] ">Mizrak 2009</a>). </p> </li> <li> <p>Ketamine considered to have pharmacological effects related not only to sedation; therefore trials involving the use of ketamine excluded (<a href="./references#CD009763-bbs2-0019" title="AbdallahCG , FasulaM , KelmendiB , SanacoraG , OstroffR . Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting. The Journal of ECT2012;28(3):157‐61. [MEDLINE: 22847373] ">Abdallah 2012</a>; <a href="./references#CD009763-bbs2-0024" title="Erdogan KayhanG , YucelA , ColakYZ , OzgulU , YologluS , KarlıdagR , et al. Ketofol (mixture of ketamine and propofol) administration in electroconvulsive therapy. Anaesthesia and Intensive Care2012;40(2):305‐10. [MEDLINE: 22417026] ">Erdogan 2012</a>; <a href="./references#CD009763-bbs2-0034" title="WangX , ChenY , ZhouX , LiuF , ZhangT , ZhangC . Effects of propofol and ketamine as combined anaesthesia for electroconvulsive therapy in patients with depressive disorder. The Journal of ECT2012;28(2):128‐32. [MEDLINE: 22622291] ">Wang 2012</a>; <a href="./references#CD009763-bbs2-0035" title="YalcinS , AydoğanH , SelekS , KucukA , YuceHH , KarababaF , et al. Ketofol in electroconvulsive therapy anaesthesia: two stones for one bird. Journal of Anesthesia2012;26(4):562‐7. [MEDLINE: 22623080] ">Yalcin 2012</a>). </p> </li> </ol> </p> <section id="CD009763-sec-0076"> <h5 class="title">Studies awaiting classification</h5> <p>We reran the search in February 2017. There are four studies awaiting classification (<a href="./references#CD009763-bbs2-0036" title="CanbekO , IpekcıogluD , MengesOO , Atagun , ML , KaramustafalıogluN , CetinkayaOZ , et al. Comparison of propofol, etomidate, and thiopental in anesthesia for electroconvulsive therapy: a randomized, double‐blind clinical trial. Journal of ECT2015;31:91‐7. [PUBMED: 25268043] ">Canbek 2015</a>; <a href="./references#CD009763-bbs2-0037" title="JarineshinH , KashaniS , FekratF , VatankhahM , GolmirzaeiJ , AlimolaeeE , et al. Seizure duration and hemodynamic state during electroconvulsive therapy: sodium thiopental versus propofol. Global Journal of Health Science2016;8(2):126‐31. [PUBMED: 26383207] ">Jarineshin 2016</a>; <a href="./references#CD009763-bbs2-0038" title="MirAH , ShahNF , DinMU , LangooSA , ReshiFA . Effectiveness of sodium thiopentone, propofol, and etomidate as an idealintravenous anesthetic agent for modifed electroconvulsive therapy.. Saudi Journal of Anaesthesia2017;11:26‐31. [PUBMED: 28217049] ">Mir 2017</a>; <a href="./references#CD009763-bbs2-0039" title="PurtuloğluT , ÖzdemirB , ErdemM , DenizS , BalkçA , ÜnlüG , ÖznurT . Effect of propofol Versus sodium thiopental on electroconvulsive therapy in major depressive disorder: a randomized double‐blind controlled clinical trial. Journal of ECT2013;29:37‐40. [PUBMED: 23377746 ] ">Purtuloğlu 2013</a>). For further details see <a href="./references#CD009763-sec-0132" title="">Characteristics of studies awaiting classification</a>. </p> <p>Ongoing studies</p> <p>We identified one ongoing study (<a href="./references#CD009763-bbs2-0040" title="The relationship between anaesthetic induction agent type or dose and clinical outcome in patients with depression undergoing electroconvulsive therapy (ECT). Ongoing study 01/03/2003. ">Godfrey 2011</a>). For further details see <a href="./references#CD009763-sec-0133" title="">Characteristics of ongoing studies</a> </p> </section> </section> </section> <section id="CD009763-sec-0077"> <h3 class="title">Risk of bias in included studies</h3> <p>For general information on the risk of bias in all included trials, please refer to <a href="#CD009763-fig-0002">Figure 2</a> and <a href="#CD009763-fig-0003">Figure 3</a>. </p> <p>For additional methodological details, please see <a href="./references#CD009763-sec-0130" title="">Characteristics of included studies</a>. </p> <section id="CD009763-sec-0078"> <h4 class="title">Allocation</h4> <p>All trials were reported to be randomized. Methods of randomization (sequence generation) were described in four trials (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0006" title="ErdilF , DemirbilekS , BegecZ , OzturkE , ErsoyMO . Effects of propofol or etomidate on QT interval during electroconvulsive therapy. The Journal of ECT2009;25:174‐7. [MEDLINE: 19225403] ">Erdil 2009</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a>). Two studies (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>) reported details of allocation concealment and were counted as 'low risk'; the remaining included studies were classified as 'unclear risk' associated with moderate to high risk of selection bias. </p> </section> <section id="CD009763-sec-0079"> <h4 class="title">Blinding</h4> <p>Nine studies reported the use of blinding for outcome assessment and were assessed as 'low risk' of bias (<a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a>; <a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>; <a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>; <a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>; <a href="./references#CD009763-bbs2-0014" title="MattersRM , BeckettWG , KirkbyKC , KingTE . Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. British Journal of Anesthesia1995;75:297‐300. [MEDLINE: 7547047] ">Matters 1995</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a>). The remaining included studies did not describe blinding of rater (evaluator) or participants and were classified as 'unclear risk' of bias associated with moderate to high risk of performance and detection bias. No study evaluated the success of blinding of rater or participants. </p> </section> <section id="CD009763-sec-0080"> <h4 class="title">Incomplete outcome data</h4> <p>In the outcome reporting, five studies reported early dropout or exclusion of enrolled participants for various reasons. </p> <p> <ol id="CD009763-list-0011"> <li> <p>One participant withdrew consent and another was excluded for delirium during the first ECT provided in the midazolam group (<a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>). </p> </li> <li> <p>Two participants were excluded for protocol violation (different medications administered for anaesthesia) and one participant declined ECT (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>). </p> </li> <li> <p>Two participants were excluded for early discontinuation of ECT unrelated to the study: one for incorrect use of intravenous lidocaine and another for emergence delirium under the use of both thiopental and propofol (<a href="./references#CD009763-bbs2-0005" title="ButterfieldNN , GrafP , MacleodBA , RiesCR , ZisAP . Propofol reduces cognitive impairment after electroconvulsive therapy. The Journal of ECT2004;20:3‐9. [MEDLINE: 5087989] ">Butterfield 2004</a>). </p> </li> <li> <p>Five participants were excluded for incomplete data collection (<a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a>). </p> </li> <li> <p>Four participants were excluded for personal or family refusal of ECT, three participants for referred psychiatrist refusal of ECT, one participant for incorrect use of anti‐depressant medication and another three participants for stimulus energy not in accordance with the protocol (five in the propofol group and six in the methohexital group) (<a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>). </p> </li> </ol> </p> <p>Dropout rates between these interventional groups are comparable, and no statistical difference was found; other trials included all eligible participants in the data analysis. </p> <p>These trials were still rated as 'high risk'. The remaining 13 trials stated that all enrolled participants were included in the analysis and that no dropouts were found; therefore we rated them as 'low risk' of bias. </p> </section> <section id="CD009763-sec-0081"> <h4 class="title">Selective reporting</h4> <p>Efficacy of anti‐depression, seizure quality, recovery time and postanaesthetic adverse events are the focus of the analysis. None of the trials lacked one or more reported results on all outcomes. The most common outcome was absence of reporting of adverse events. </p> <p>We also found absence of reporting of anti‐depression efficacy in eight of the included trials. </p> <p>Time to recovery was not reported in six of the included trials. We rated trials missing recording of postanaesthetic cognitive evaluation as 'high risk' for reporting bias. </p> </section> <section id="CD009763-sec-0082"> <h4 class="title">Other potential sources of bias</h4> <p>No description of other potential sources of bias was included in all 18 included studies. </p> </section> </section> <section id="CD009763-sec-0083"> <h3 class="title" id="CD009763-sec-0083">Effects of interventions</h3> <p>See: <a href="./full#CD009763-tbl-0001"><b>Summary of findings for the main comparison</b> Methohexital compared with propofol for depressive patients receiving MECT</a>; <a href="./full#CD009763-tbl-0002"><b>Summary of findings 2</b> Thiopental compared with propofol for patients receiving ECT</a> </p> <section id="CD009763-sec-0084"> <h4 class="title">Change in depression scores</h4> <p>Four trials including 165 participants compared propofol versus methohexital (<a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a>; <a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>) and reported the change in Hamilton Depression Scale (HDS) scores. No difference in the change in HDS (mean difference [MD] = baseline score minus post‐treatment score) was noted among participants who underwent anaesthesia with methohexital compared with propofol (<a href="./references#CD009763-fig-0007" title="">Analysis 1.1</a>) (see <a href="#CD009763-fig-0004">Figure 4</a>). Electrode placement (unilateral vs bilateral) did not influence the results (<a href="./references#CD009763-fig-0007" title="">Analysis 1.1</a>). Two studies used unilateral electrode placement (<a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a>), one study switched from unilateral electrode placement to bilateral (<a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>) and another study used bilateral electrode placement in all participants (<a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>). These studies were not designed to determine differences in HDS scores and showed higher baseline and post‐treatment HDS scores in the methohexital group (<a href="./references#CD009763-fig-0008" title="">Analysis 1.2</a>; <a href="./references#CD009763-fig-0009" title="">Analysis 1.3</a>). </p> <div class="figure" id="CD009763-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.1 Change in Hamilton Depression Scale (HDS) score." data-id="CD009763-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.1 Change in Hamilton Depression Scale (HDS) score. </p> </div> </div> </div> <p>Multiple orphan trials compared depression scores using different scales at different time points after completion of ECT (<a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a>; <a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>). No difference in the reduction in depression scores was noted when methohexital was compared with propofol or midazolam (<a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>; <a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>). Propofol and etomidate showed greater reduction in depression scores when compared with thiopental, but no difference in the number of participants achieving clinical improvement was noted (&gt; 50% reduction in HDS scores or HDS &lt; 10) (<a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a>; <a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>). </p> <p>In one study, unilateral electrode placement was changed to bilateral electrode placement if participants did not show satisfactory clinical improvement (<a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>). It is interesting to note that more participants in the methohexital group required this intervention compared with those in the propofol group (12/29 vs 4/29; P value 0.038). </p> <p>No data were available or only single trials compared the remaining comparisons (<a href="./full#CD009763-tbl-0001">summary of findings Table for the main comparison</a>) (see <a href="./appendices#CD009763-sec-0108">Appendix 8</a>, <a href="./appendices#CD009763-sec-0109">Appendix 9</a>, <a href="./appendices#CD009763-sec-0110">Appendix 10</a> and <a href="./appendices#CD009763-sec-0111">Appendix 11</a>). </p> </section> <section id="CD009763-sec-0085"> <h4 class="title">EEG seizure duration</h4> <p>Two trials including 108 participants compared propofol with methohexital (<a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>), and two trials including 90 participants compared propofol with thiopental (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>). </p> <p>Propofol showed a significant reduction in EEG seizure duration compared with methohexital (P value 0.04) (<a href="./references#CD009763-fig-0010" title="">Analysis 1.4</a>) (see <a href="#CD009763-fig-0005">Figure 5</a>). No difference in EEG seizure duration was seen when propofol was compared with thiopental (P value 0.83) (<a href="./references#CD009763-fig-0012" title="">Analysis 2.1</a>). </p> <div class="figure" id="CD009763-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.4 EEG seizure duration (seconds)." data-id="CD009763-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.4 EEG seizure duration (seconds). </p> </div> </div> </div> <p>No data were available or only single trials compared the remaining intravenous anaesthetics; see <a href="./full#CD009763-tbl-0002">summary of findings Table 2</a> and <a href="./appendices#CD009763-sec-0109">Appendix 9</a>, <a href="./appendices#CD009763-sec-0112">Appendix 12</a>, <a href="./appendices#CD009763-sec-0113">Appendix 13</a> and <a href="./appendices#CD009763-sec-0114">Appendix 14</a>. </p> </section> <section id="CD009763-sec-0086"> <h4 class="title">Motor seizure duration</h4> <p>Two trials including 78 participants compared propofol with methohexital (<a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>; <a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>). </p> <p>Participants treated with propofol showed a significantly shorter motor seizure duration than participants treated with methohexital (P value 0.003) (<a href="./references#CD009763-fig-0011" title="">Analysis 1.5</a>) (see <a href="#CD009763-fig-0006">Figure 6</a>). No data were available or only single trials compared the remaining comparisons. </p> <div class="figure" id="CD009763-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.5 Motor seizure duration (seconds)." data-id="CD009763-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.5 Motor seizure duration (seconds). </p> </div> </div> </div> <p>In single trials, no difference in motor seizure duration was noted when methohexital was compared with propofol (<a href="./references#CD009763-bbs2-0014" title="MattersRM , BeckettWG , KirkbyKC , KingTE . Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. British Journal of Anesthesia1995;75:297‐300. [MEDLINE: 7547047] ">Matters 1995</a>) or with midazolam (<a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a>). Motor seizure duration was longer when thiopental was compared with propofol or with midazolam (<a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a>). Participants treated with etomidate showed a longer motor seizure duration than those treated with methohexital (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>; <a href="./references#CD009763-bbs2-0010" title="GratiL , LouziM , NasrK , ZiliN , MansalliL , MechriA , et al. [Compared effects of etomidate and propofol for anaesthesia during electroconvulsive therapy] (Article in French). La Presse Médicale2005;34:282‐4. [MEDLINE: 15798546] ">Grati 2005</a>). A single cross‐over study reported no difference in motor seizure duration when etomidate was compared with propofol (<a href="./references#CD009763-bbs2-0006" title="ErdilF , DemirbilekS , BegecZ , OzturkE , ErsoyMO . Effects of propofol or etomidate on QT interval during electroconvulsive therapy. The Journal of ECT2009;25:174‐7. [MEDLINE: 19225403] ">Erdil 2009</a>). See <a href="./full#CD009763-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD009763-tbl-0002">summary of findings Table 2</a>; also see <a href="./appendices#CD009763-sec-0109">Appendix 9</a>, <a href="./appendices#CD009763-sec-0111">Appendix 11</a>, and <a href="./appendices#CD009763-sec-0113">Appendix 13</a> to <a href="./appendices#CD009763-sec-0117">Appendix 17</a>. </p> </section> <section id="CD009763-sec-0087"> <h4 class="title">Time to recovery (following commands)</h4> <p>Two trials including 48 participants compared propofol versus thiopental (<a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>). After anaesthesia, participants with thiopental recovered more slowly than those given propofol (P value 0.006) (<a href="./references#CD009763-fig-0013" title="">Analysis 2.2</a>). Time to eye opening was reported in multiple studies, but this endpoint is potentially influenced by ambient noise. These data were not included. </p> <p>No data were available or only single trials performed the remaining comparisons.</p> <p>Multiple orphan trials reported time to recovery. Participants after anaesthesia given propofol recovered more quickly than those given etomidate or thiopental (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>; <a href="./references#CD009763-bbs2-0005" title="ButterfieldNN , GrafP , MacleodBA , RiesCR , ZisAP . Propofol reduces cognitive impairment after electroconvulsive therapy. The Journal of ECT2004;20:3‐9. [MEDLINE: 5087989] ">Butterfield 2004</a>; <a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>). No difference in time to recovery was noted when etomidate was compared with thiopental (<a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>) or with methohexital (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>), and no difference was observed when propofol was compared with thiamylal (<a href="./references#CD009763-bbs2-0017" title="SakamotoA , HoshinoT , SuzukiN , SuzukiH , KimuraM , OgawaR . Effects of propofol anaesthesia on cognitive recovery of patients undergoing electroconvulsive therapy. Psychiatry and Clinical Neurosciences1999;53:655‐60. [MEDLINE: 10687746] ">Sakamoto 1999</a>). A single cross‐over study reported no difference in time to recovery when etomidate was compared with propofol (<a href="./references#CD009763-bbs2-0006" title="ErdilF , DemirbilekS , BegecZ , OzturkE , ErsoyMO . Effects of propofol or etomidate on QT interval during electroconvulsive therapy. The Journal of ECT2009;25:174‐7. [MEDLINE: 19225403] ">Erdil 2009</a>); see <a href="./appendices#CD009763-sec-0109">Appendix 9</a>, <a href="./appendices#CD009763-sec-0110">Appendix 10</a>, <a href="./appendices#CD009763-sec-0112">Appendix 12</a> to <a href="./appendices#CD009763-sec-0114">Appendix 14</a> and <a href="./appendices#CD009763-sec-0118">Appendix 18</a>. </p> </section> <section id="CD009763-sec-0088"> <h4 class="title">Adverse events</h4> <p>Data were insufficient for pooling, and outcome was reported in single studies. Observed adverse events did not differ between propofol, thiopental, etomidate and midazolam. No study reported cognitive adverse events (see <a href="./appendices#CD009763-sec-0119">Appendix 19</a> to <a href="./appendices#CD009763-sec-0121">Appendix 21</a>). </p> <p>Most studies showed a great degree of heterogeneity. After very low‐quality trials were excluded, the sensitivity analysis did not significantly change the statistical results. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009763-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009763-sec-0089"></div> <section id="CD009763-sec-0090"> <h3 class="title" id="CD009763-sec-0090">Summary of main results</h3> <p>In this systematic review, we evaluated the efficacy and safety of different regimens of sedatives or hypnotics for anaesthesia of ECT. We included 18 trials (599 participants). The anaesthetic medications used in these trials were propofol, methohexital, thiopental, etomidate, midazolam and thiamylal. Included trials investigated nine possible combinations of anaesthetic medications. Data could be pooled only on studies comparing propofol with methohexital (four trials) and with thiopental (three trials). Cross‐over studies were not pooled in the analysis. </p> <p>No difference in the reduction in depression scores was reported among different anaesthetics. These studies were not designed to detect differences in depression scores. </p> <p>Propofol seems to reduce EEG and motor seizure duration compared with methohexital and possibly with etomidate. No difference in EEG seizure duration was described when propofol was compared with thiopental. Motor seizure duration was longer after induction of anaesthesia with methohexital compared with propofol (see <a href="#CD009763-tbl-0005">Table 3</a>). Recovery times were shorter in participants treated with propofol compared with thiopental. </p> <div class="table" id="CD009763-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Comparisons of seizure duration</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pairs of comparisons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Agents with longer<b>seizure duration</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methohexital versus propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methohexital (EEG and motor)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thiopental versus propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Etomidate versus propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Etomidate (motor)</p> </td> </tr> </tbody> </table> </div> <p>The paucity of trials reporting postanaesthesia adverse events did not allow an analysis of comparative safety between methohexital and propofol. No differences were found between propofol and thiopental or etomidate in terms of adverse events. </p> </section> <section id="CD009763-sec-0091"> <h3 class="title" id="CD009763-sec-0091">Overall completeness and applicability of evidence</h3> <p>All included trials were small and were conducted at single centres. No clear consensus was reached on defining the 'ideal' seizure quality that would be most effective in reducing depressive symptoms. The American Psychiatric Association recommends a motor seizure duration of greater than 20 seconds (<a href="./references#CD009763-bbs2-0041" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000. ">American Psychiatric Association 2000</a>). Differences in energies, waveforms and electrode placement influence the results. Included anaesthetics influence seizure duration to different degrees. Because of the unclear or controversial effects of seizure duration on reduction of depressive symptoms, it remains unclear whether the effect, for instance, of propofol in reducing seizure duration compared with methohexital is clinically relevant. </p> <p>The number of ECT sessions in the studies is determined by participant response and improvement. Typical clinical endpoints at the conclusion of treatment are: </p> <p> <ol id="CD009763-list-0012"> <li> <p>reduction in HDS scores greater than 50%;</p> </li> <li> <p>HDS score less than a fixed number;</p> </li> <li> <p>no further improvement; and</p> </li> <li> <p>no improvement at all (nonresponder) (<a href="./references#CD009763-bbs2-0041" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000. ">American Psychiatric Association 2000</a>; <a href="./references#CD009763-bbs2-0058" title="IovienoN , PapakostasGI . Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta‐analysis. Journal of Clinical Psychiatry2012;10:1300‐6. [PUBMED: 23140647 ] ">Lovieno 2012</a>; <a href="./references#CD009763-bbs2-0059" title="ManeetonN , ManeetonB , SrisurapanontM , MartinSD . Quetiapine monotherapy in acute phase for major depressive disorder: a meta‐analysis of randomized, placebo‐controlled trials. BMC Psychiatry2012;12:160‐8. [PUBMED: 23017200 ] ">Maneeton 2012</a>). </p> </li> </ol> </p> <p>This means that treatments are continued until one endpoint is met. Pooling of final scores simply reflects that participants achieved one of the endpoints and that treatment was successful. An ideal study investigating the effects of intravenous anaesthetics would need to show that the decline in depression scores is faster and/or that participants require fewer treatments to achieve a preset goal without altering any co‐variants (e.g. energy or electrode placement), although it would be difficult to determine how data from participants who do not improve with ECT (non‐responders) should be handled. Clinically the first step is to change the treatment modality, in this case ECT (titration), rather than a secondary variable, in this case anaesthetics. If an anaesthetic has a positive effect on depression scores, this would be evident in the decline in depression scores (not the final score) or in the total number of ECT sessions needed. Some included trials were cross‐over studies, which did not allow comparison of this endpoint because participants were exposed to both medications. </p> <p>Evidence for other pairs of comparisons was obtained from small trials, and follow‐up ended at different time points. </p> </section> <section id="CD009763-sec-0092"> <h3 class="title" id="CD009763-sec-0092">Quality of the evidence</h3> <p>In this systematic review, most included randomized controlled studies were small and of low quality. Only two trials showed high methodological quality, reporting Hamilton Depression Rating Scale scores, seizure duration, fluctuations in blood pressure and a variety of postanaesthetic cognitive tests (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>). </p> <p>The presentation and the statistical methodology in most trials could be debated. Depression scale scores (e.g. from the HDS, an ordinal scale) are presented as means with SDs instead of medians with interquartile ranges (IQRs). Further, the study authors used statistical tests for continuous data (e.g. Student‐t, analysis of variance (ANOVA), linear regression) to analyse depression scores (ordinal data). This becomes a matter of particular concern when evidence seems to show that "not all items of the HDS are equally sensitive to detect responding patients in clinical trials" (<a href="./references#CD009763-bbs2-0067" title="SantenG , GomeniR , DanhofM , Della PasquaO . Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy. Journal of Psychiatric Research2008;42(12):1000‐9. [PUBMED: 18206909 ] ">Santen 2008</a>). Further, the 'independence' of experiments does influence the type of statistical test necessary to analyse the data. Does the ECT done two days ago influence the result of the ECT done today in the same participant? The answer to this question (independence and repeated measurement) should guide statistical methods used to analyse study results. </p> <p>Another limitation was that different times were used to follow up on or to reassess depression scores after ECT sessions. Some trials reported depression scores right after ECT, whereas others waited eight weeks. It would be preferable to have clinical guidelines on assessing depression scores after ECT (<a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>; <a href="./references#CD009763-bbs2-0068" title="SteidtmannD , ManberR , BlaseyC , MarkowitzJC , KleinDN , RothbaumBO , et al. Detecting critical decision points in psychotherapy and psychotherapy + medication for chronic depression. Journal of Consulting and Clinical Psychology2013;81(5):783‐92. [PUBMED: 23750462 ] ">Steidtmann 2013</a>). </p> </section> <section id="CD009763-sec-0093"> <h3 class="title" id="CD009763-sec-0093">Potential biases in the review process</h3> <p>Only two studies showed a low degree of bias (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>). All remaining studies showed a high degree of bias. In this systematic review, the overall quality of evidence for different regimens of intravenous sedatives or hypnotics for the primary outcome (reduction in HDS scores) is low, and for postanaesthetic adverse events including cognitive events, it is very low. </p> </section> <section id="CD009763-sec-0094"> <h3 class="title" id="CD009763-sec-0094">Agreements and disagreements with other studies or reviews</h3> <p>Currently, intravenous sedatives or hypnotics are used for induction of anaesthesia for ECT. This review aimed to investigate the comparative efficacy and safety of intravenous anaesthetics. This was the first review that used pooled data to investigate anti‐depression efficacy of anaesthetic agents used for ECT. </p> <p>No difference in the reduction in depression scores was observed when propofol was compared with methohexital. </p> <p>Participants receiving methohexital or etomidate showed significantly longer seizure duration compared with those given propofol. These results were similar to findings described in previous reports (<a href="./references#CD009763-bbs2-0050" title="GaborG , JuditT , ZsoltI . Comparison of propofol and etomidate regarding impact on seizure threshold during electroconvulsive therapy in patients with schizophrenia. Neuropsychopharmacologia Hungarica2007;9(3):125‐30. [PUBMED: 18399030] ">Gabor 2007</a>; <a href="./references#CD009763-bbs2-0051" title="GazdagG , KocsisN , TolnaJ , IvanyiZ . Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. The Journal of ECT2004;20(4):225‐9. ">Gazdag 2004</a>; <a href="./references#CD009763-bbs2-0023" title="ErantiSV , MoggAJ , PluckGC , LandauS , McLoughlinDM . Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: a naturalistic comparison study. Journal of Affective Disorders2009;113:165‐71. [MEDLINE: 18439686] ">Eranti 2009</a>; <a href="./references#CD009763-bbs2-0032" title="TanHL , LeeCY . Comparison between the effects of propofol and etomidate on motor and electroencephalogram seizure duration during electroconvulsive therapy. Anaesthesia and Intensive Care2009;37:807‐14. [MEDLINE: 19775046] ">Tan 2009</a>; <a href="./references#CD009763-bbs2-0071" title="WalderB , SeeckM , TramèrMR . Propofol versus methohexital for electroconvulsive therapy: a meta‐analysis. Journal of Neurosurgical Anesthesiology2001;13(2):93‐8. [MEDLINE: 11294464] ">Walder 2001</a>). It seems that higher doses of propofol reduce seizure duration to a greater extent when compared with increasing doses of methohexital or etomidate (<a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a>). No differences in seizure duration were noted when propofol was compared with thiopental. Single eligible trials with significant methodological heterogeneity (<a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; <a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>) and trials that included participants with multiple psychiatric diseases reported longer seizure duration with thiopental (<a href="./references#CD009763-bbs2-0048" title="BoeyWK , LaiFO . Comparison of propofol and thiopentone as anaesthetic agents for electroconvulsive therapy. Anaesthesia1990;45(8):623‐8. [PUBMED: 2400070] ">Boey 1990</a>; <a href="./references#CD009763-bbs2-0033" title="VillalongaA , BernardoM , GomarC , FitaG , EscobarR , PachecoM . Cardiovascular response and anaesthetic recovery in electroconvulsive therapy with propofol and thiopental. Convulsive Therapy1992;9(2):108‐11. [MEDLINE: 11941199] ">Villalonga 1993</a>). Larger trials are needed to clarify this question. </p> <p>In our review, cognitive recovery was measured as time to obey commands. No difference was seen between propofol, methohexital and etomidate, but thiopental seem to prolong recovery times. This finding was in accordance with those of systematic reviews of other psychiatric diseases (<a href="./references#CD009763-bbs2-0056" title="HootenWM , RasmussenKG . Effects of general anaesthetic agents in adults receiving electroconvulsive therapy: a systematic review. The Journal of ECT2008;24:208‐23. [PUBMED: 18628717] ">Hooten 2008</a>; <a href="./references#CD009763-bbs2-0071" title="WalderB , SeeckM , TramèrMR . Propofol versus methohexital for electroconvulsive therapy: a meta‐analysis. Journal of Neurosurgical Anesthesiology2001;13(2):93‐8. [MEDLINE: 11294464] ">Walder 2001</a>). Propofol has a well‐established favourable recovery profile, making it the preferred hypnotic for short procedures with minimal discomfort, such as endoscopies (<a href="./references#CD009763-bbs2-0044" title="Recommendations on the administration of sedation for the performance of endoscopic procedures: a joint statement of a working group from the American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA) and the American Society for Gastrointestinal Endoscopy (ASGE). &lt;http://www.gastro.org/wmspage.cfm?parm1=371&gt; (version current at 3 March 2008). ">ASGE 2008</a>). </p> <p>Anaesthesia‐related adverse events were rarely reported in eligible trials, and the incidence was low. Several reasons might account for this. Follow‐up duration may not have been adequate to detect adverse events. This finding also might have been the result of enrolment of participants with relatively low risk (American Society of Anesthesiologists (ASA) I and II). Based on current evidence, nausea and vomiting were more frequent for thiopental and etomidate than for propofol. Headache and delirium occurred more frequently in participants receiving midazolam compared with thiopental. Myoclonus was reported only in the etomidate group. The profile of adverse events was in accordance with the anaesthesia literature (<a href="./references#CD009763-bbs2-0054" title="HinesR , BarashPG , WatrousG , O'ConnorT . Complications occurring in the postanesthesia care unit: a survey. Anesthesia and Analgesia1992;74(4):503‐9. [PUBMED: 1554116] ">Hines 1992</a>). In conclusion, reporting of adverse events was neglected or heterogeneous in included trials. One adverse outcome was entirely neglected in depressive participants: adrenal suppression with etomidate. Lowered cortisol levels and disrupted circadian rhythm of its release have played a role in the pathogenesis of depression (<a href="./references#CD009763-bbs2-0055" title="HollandJM , SchatzbergAF , O'HaraR , MarquettRM , Gallagher‐ThompsonD . Pretreatment cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy. Psychiatry Research 2013;13 [Epub ahead of print]. [DOI: http://dx.doi.org/10.1016/j.psychres.2013.07.033i] ">Holland 2013</a>). Measurements of cortisol and adrenocorticotropic hormone after ECT did not show a significant difference between propofol and etomidate in participants with affective disorder and schizophrenia (<a href="./references#CD009763-bbs2-0072" title="WangN , WangXH , LuJ , ZhangJY . The effect of repeated etomidate anesthesia on adrenocortical function during a course of electroconvulsive therapy. Journal of ECT2011;27(4):281‐5. [PUBMED: 22080238] ">Wang 2011</a>). Future studies should help to clarify this issue in depressive patients. </p> <p>For other pairs of agents, one common problem was that all evidence came from several single low‐ to very low‐quality trials and from orphan studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009763-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009763-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009763-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009763-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.1 Change in Hamilton Depression Scale (HDS) score." data-id="CD009763-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.1 Change in Hamilton Depression Scale (HDS) score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.4 EEG seizure duration (seconds)." data-id="CD009763-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.4 EEG seizure duration (seconds). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.5 Motor seizure duration (seconds)." data-id="CD009763-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Methohexital versus propofol, outcome: 1.5 Motor seizure duration (seconds). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Methohexital versus propofol, Outcome 1 Change in Hamilton Depression Scale (HDS) score." data-id="CD009763-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Methohexital versus propofol, Outcome 1 Change in Hamilton Depression Scale (HDS) score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#CD009763-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Methohexital versus propofol, Outcome 2 Baseline Hamilton Depression Scale score." data-id="CD009763-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Methohexital versus propofol, Outcome 2 Baseline Hamilton Depression Scale score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#CD009763-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Methohexital versus propofol, Outcome 3 Post‐treatment Hamilton Depression Scale score." data-id="CD009763-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Methohexital versus propofol, Outcome 3 Post‐treatment Hamilton Depression Scale score. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#CD009763-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Methohexital versus propofol, Outcome 4 EEG seizure duration (seconds)." data-id="CD009763-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Methohexital versus propofol, Outcome 4 EEG seizure duration (seconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#CD009763-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Methohexital versus propofol, Outcome 5 Motor seizure duration (seconds)." data-id="CD009763-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Methohexital versus propofol, Outcome 5 Motor seizure duration (seconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#CD009763-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Thiopental versus propofol, Outcome 1 EEG seizure duration (seconds)." data-id="CD009763-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Thiopental versus propofol, Outcome 1 EEG seizure duration (seconds).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#CD009763-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009763-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/urn:x-wiley:14651858:media:CD009763:CD009763-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_t/tCD009763-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Thiopental versus propofol, Outcome 2 Time to recovery (minutes)." data-id="CD009763-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Thiopental versus propofol, Outcome 2 Time to recovery (minutes).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#CD009763-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/media/CDSR/CD009763/image_n/nCD009763-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009763-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Methohexital compared with propofol for depressive patients receiving MECT</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Methohexital compared to propofol for depressive patients receiving MECT</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with depressive patients receiving MECT<br/> <b>Settings:</b> in‐patients and outpatients<br/> <b>Intervention:</b> methohexital<br/> <b>Comparison:</b> propofol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Propofol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Methohexital </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in Hamilton Depression Scale scores</b> <br/> Scale of Hamilton Depression scores<br/> Follow‐up: from start of ECT to 8 weeks after last session of ECT </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in Hamilton depression scores in the control groups was<br/> <b>the mean change in HDS before and after MECT treatment</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean change in Hamilton Depression Scale scores in the intervention groups was<br/> <b>1.10 higher</b> <br/> (0.56 lower to 2.77 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>;<a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>;<a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a>;<a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EEG seizure duration</b> <br/> EEG detection and measurement<br/> Follow‐up: from start of RCT (mean number as 2.5) to 2 months after ECT months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean EEG seizure duration in the control groups was<br/> <b>0 average participants (second)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean EEG seizure duration in the intervention groups was<br/> <b>7.42 higher</b> <br/> (0.39 to 14.4 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a>;<a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Motor seizure duration</b> <br/> Direct observation of motor seizure<br/> Follow‐up: number of ECT sessions (6.6 to 7.8) per participant </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean motor seizure duration in the control groups was<br/> <b>0 seconds</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean motor seizure duration in the intervention groups was<br/> <b>5.87 higher</b> <br/> (1.97 to 9.77 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>78<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a>;<a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Length of follow‐up period was different among included studies.<br/> <sup>2</sup>Small samples might render the pooled results imprecise.<br/> <sup>3</sup>All data were retrieved from published trials and no unpublished data were identified.<br/> <sup>4</sup>The report of all trials was published and no unpublished data were detected. </p> <p>5Heterogeneity might exist in baseline features of included participants.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Methohexital compared with propofol for depressive patients receiving MECT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009763-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Thiopental compared with propofol for patients receiving ECT</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Propofol versus thiopental</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with major depression treated with ECT<br/> <b>Settings:</b> in‐patients<br/> <b>Intervention:</b> thiopental<br/> <b>Comparison:</b> propofol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Propofol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Thiopental </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean EEG seizure duration</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 second</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2.26 seconds</b> <br/> (‐18.35 to 22.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a>; </p> <p><a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean time to recovery</b> <br/> Time to follow commands </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 minutes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1.72 minutes</b> <br/> (0.49 to 2.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a>; </p> <p><a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Follow‐up durations were different among included studies.<br/> <sup>2</sup>Performance and detection bias were likely to happen in the trials.<br/> <sup>3</sup>Samples were small, which carries risk of inaccuracy.<br/> <sup>4</sup>Heterogeneity in baseline characteristics existed. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Thiopental compared with propofol for patients receiving ECT</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009763-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">List of abbreviations used in this review</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abbreviation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Full name</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ECT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Electroconvulsive therapy (synonym for modified electrioconvulsive therapy in this review) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MADRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Montgomery‐Asberg Depression Scale</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HDRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hamilton Depression Rating Scale</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DSM‐IV</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition</i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>WHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World Health Orgnization</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DALY</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disability‐adjusted life‐year</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>*</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">List of abbreviations used in this review</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009763-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Doses of anaesthetics in mg/kg</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methohexital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thiopental</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Etomidate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Midazolam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thiamylal</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0003" title="AvramovMN , HusainMM , WhitePF . The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and Analgesia1995;81:596‐602. [MEDLINE: 7653829] ">Avramov 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75‐1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75‐1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15‐0.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0007" title="FearCF , LittlejohnsCS , RouseE , McQuailP . Propofol anaesthesia in electroconvulsive therapy reduced seizure duration may not be relevant. British Journal of Psychiatry1994;165:506‐9. [MEDLINE: 7848492] ">Fear 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0008" title="FredmanB , d'EtienneJ , SmithI , HusainMM , WhitePF . Anesthesia for electroconvulsive therapy: effects of propofol and methohexital on seizure activity and recovery. Anesthesia and Analgesia1994;79:75‐9. [MEDLINE: 8010457] ">Fredman 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0009" title="GeretseggerC , NickelM , JudendorferB , RochowanskiE , NovakE , AichhornW . Propofol and methohexital as anaesthetic agents for electroconvulsive therapy: a randomized, double‐blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. The Journal of ECT2007;23(4):234‐43. [MEDLINE: 18090696] ">Geretsegger 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0011" title="KirkbyKC , BeckettWG , MattersRM , KingTE . Comparison of propofol and methohexitone in anaesthesia for ECT: effect on seizure duration and outcome. Australian and New Zealand Journal of Psychiatry1995;29:299‐303. [MEDLINE: 7487795] ">Kirkby 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0013" title="MalschE , GratzI , ManiS , BackupC , LevyS , AllenE . Efficacy of electroconvulsive therapy after propofol and methohexital anaesthesia. Convulsive Therapy1994;10(3):212‐9. [MEDLINE: 7834258] ">Malsch 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0014" title="MattersRM , BeckettWG , KirkbyKC , KingTE . Recovery after electroconvulsive therapy: comparison of propofol with methohexitone anaesthesia. British Journal of Anesthesia1995;75:297‐300. [MEDLINE: 7547047] ">Matters 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0004" title="BauerJ , HagemanI , DamH , BáezA , BolwigT , RoedJ , et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. The Journal of ECT2009;25:85‐90. [MEDLINE: 19092676] ">Bauer 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0005" title="ButterfieldNN , GrafP , MacleodBA , RiesCR , ZisAP . Propofol reduces cognitive impairment after electroconvulsive therapy. The Journal of ECT2004;20:3‐9. [MEDLINE: 5087989] ">Butterfield 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0012" title="KumarA , SharmaDK , ManiR . A comparison of propofol and thiopentone for electroconvulsive therapy. Journal of Anaesthesiology, Clinical Pharmacology2012;28(3):353‐7. [MEDLINE: 22869944] ">Kumar 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0015" title="RosaMA , RosaMO , BelegardeIM , BuenoCR , FregniF . Recovery after ECT: comparison of propofol, etomidate and thiopental. Revista Brasileira de Psiquiatria: Orgão Oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latin2008;30(2):149‐51. [MEDLINE: 18470404] ">Rosa 2008a</a>; <a href="./references#CD009763-bbs2-0016" title="RosaMA , RosaMO , MarcolinMA , FregniF . Cardiovascular effects of anaesthesia in ECT: a randomized, double‐blind comparison of etomidate, propofol, and thiopental. The Journal of ECT2007;23:6‐8. [MEDLINE: 17435563] ">Rosa 2008b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0‐1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0‐3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0018" title="ShahPJ , DubeyKP , WattiC , LalwaniJ . Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: a comparative study. Indian Journal of Anaesthesia2010;54(4):296‐301. [MEDLINE: 20882170] ">Shah 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0001" title="AbdollahiMH , IzadiA , HajiesmaeiliMR , GhanizadehA , DastjerdiG , HosseiniHA , et al. Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double‐blind controlled clinical trial. The Journal of ECT2012;28:10‐3. [MEDLINE: 21983758] ">Abdollahi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0002" title="AuriacombeM , GrabotD , LincheneauPM , ZeiterD , TignolJ . Use of midazolam for ECT anaesthesia: effects on antidepressive efficacy and seizure duration. Preliminary findings. European Psychiatry1995;10:312‐6. [MEDLINE: 19698359] ">Auriacombe 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0017" title="SakamotoA , HoshinoT , SuzukiN , SuzukiH , KimuraM , OgawaR . Effects of propofol anaesthesia on cognitive recovery of patients undergoing electroconvulsive therapy. Psychiatry and Clinical Neurosciences1999;53:655‐60. [MEDLINE: 10687746] ">Sakamoto 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0‐2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009763-bbs2-0010" title="GratiL , LouziM , NasrK , ZiliN , MansalliL , MechriA , et al. [Compared effects of etomidate and propofol for anaesthesia during electroconvulsive therapy] (Article in French). La Presse Médicale2005;34:282‐4. [MEDLINE: 15798546] ">Grati 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Doses of anaesthetics in mg/kg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009763-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Comparisons of seizure duration</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pairs of comparisons</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Agents with longer<b>seizure duration</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methohexital versus propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Methohexital (EEG and motor)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Thiopental versus propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Etomidate versus propofol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Etomidate (motor)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Comparisons of seizure duration</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/full#CD009763-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009763-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Methohexital versus propofol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in Hamilton Depression Scale (HDS) score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [‐0.56, 2.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Unilateral electrode placement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [‐0.55, 2.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Bilateral electrode placement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐5.22, 5.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Baseline Hamilton Depression Scale score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.59 [1.62, 5.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Post‐treatment Hamilton Depression Scale score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.49 [0.08, 4.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 EEG seizure duration (seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.42 [0.39, 14.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Motor seizure duration (seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.87 [1.97, 9.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Methohexital versus propofol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#CD009763-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009763-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Thiopental versus propofol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 EEG seizure duration (seconds) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.26 [‐18.35, 22.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Time to recovery (minutes) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [0.49, 2.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Thiopental versus propofol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009763.pub2/references#CD009763-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009763.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009763-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009763-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009763-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ru#CD009763-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009763-note-0004">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009763\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009763\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009763\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009763\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009763\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=6nHUP32m&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009763.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009763.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009763.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009763.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009763.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717795362"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009763.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717795366"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009763.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dc0a29b88936b',t:'MTc0MDcxNzc5NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 